Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
755.91 | -47.78% | -26.34% | 680,625.44 | 0.67% | 2.63% |
|
NYSE:JNJ
Johnson & Johnson
|
149.92 | 0% | 0% | 360,809.34 | 3.28% | 2.71% |
|
NYSE:MRK
Merck
|
128.26 | -7.99% | 5.47% | 324,886.2 | 2.39% | -19.03% |
|
NYSE:PFE
Pfizer
|
27.70 | 12.18% | 43.52% | 156,852.39 | 6.18% | -9.31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
400.16 | 8.91% | 17.54% | 103,425.09 | 0% | 30.14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
937.61 | -26.24% | -19.95% | 101,154.53 | 0% | 13.9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
43.70 | 62.96% | 73.38% | 88,584.27 | 5.43% | 13.54% |
|
NYSE:ZTS
Zoetis
|
167.23 | 32.3% | 48.67% | 76,415.28 | 1.09% | 11.19% |
|
NYSE:BAX
Baxter International Inc
|
36.91 | 74.55% | 100.89% | 18,800 | 2.88% | -3.14% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
150.31 | 0% | 0% | 19,007.02 | 0% | 0% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.60 | 1.95% | 12.16% | 13,740.18 | 4.13% | -8.55% |
|
NasdaqGS:UTHR
United Therapeutics
|
258.13 | -6.89% | 2.89% | 11,319.67 | 0% | 5.22% |
|
NYSE:CTLT
Catalent
|
56.34 | -57.3% | -6.83% | 10,107.41 | 0% | -10.41% |
|
NasdaqGS:CYTK
Cytokinetics
|
64.34 | 0% | 0% | 6,424.74 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
43.09 | -,154.22% | -,147.1% | 6,017.6 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
146.28 | -0.56% | 9% | 4,561.9 | 0.55% | 5.85% |
|
NYSE:PRGO
Perrigo Co PLC
|
33.06 | 39.65% | 63.25% | 4,425.95 | 3.36% | -15.93% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
216.05 | 0% | 0% | 4,342.48 | 0% | 0% |
|
NasdaqGS:NEOG
Neogen
|
12.45 | 135.45% | 235.73% | 2,670.77 | 0% | -1.7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
25.06 | -33.03% | -8.53% | 2,479.63 | 0% | 2.03% |
